Drug Profile
Cabazitaxel injection - Accord Healthcare
Alternative Names: Cabazitaxel - Accord HelathcareLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Accord Healthcare
- Class Amines; Antineoplastics; Benzene derivatives; Esters; Small molecules; Taxanes
- Mechanism of Action Tubulin inhibitors; Tubulin polymerisation promoters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Prostate cancer
Most Recent Events
- 29 Nov 2018 Cabazitaxel is not yet available in USA for Prostate cancer (Accord Healthcare website, November 2018)